SCHEMBL5774788

SCHEMBL5774788

Cc1cc(N2CCCCC2)c2[nH]c(-c3ccc(F)cc3)cc2n1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 19/20 0.78
NCF1 P14598 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774410 0.88 NPY5R (1.00) NPY5RNCF1
SCHEMBL5774720 0.81 NPY5R (1.00) NPY5R
SCHEMBL5777964 0.80 NPY5R (0.57) NPY5R
Hydrochloric Acid SCHEMBL5772595 0.80 NPY5R (0.98) NPY5R
SCHEMBL5773917 0.75 NPY5R (0.50) NPY5R
SCHEMBL7982268 0.73 NPY5R (0.44) NPY5RNCF1
SCHEMBL5773493 0.73 NPY5R (0.51) NPY5RNCF1
SCHEMBL5775286 0.73 NPY5R (0.79) NPY5R
SCHEMBL5771938 0.73 NPY5R (0.92) NPY5R
Hydrochloric Acid SCHEMBL5771488 0.72 NPY5R (0.50) NPY5RNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP claimed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US claimed
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed